This would be in line with the clinical phenotype of anti-MDA-5+ patients, who typically have limited muscle weakness with more severe extramuscular manifestations, such as interstitial lung disease and skin ulcerations [30]. The gene discussed is IFIH1; the disease is interstitial lung disease.